Monitoring response to treatment in asthma management: food for thought
- 4 August 2004
- journal article
- review article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 34 (8), 1168-1177
- https://doi.org/10.1111/j.1365-2222.2004.02020.x
Abstract
Asthma is a chronic inflammatory disorder of the airways that is characterized by episodic symptoms. In this regard, asthma management has classically involved periodic re-assessment by the health-care provider, during which therapy is altered mainly based on clinical and physiological parameters, such as assessment of symptoms, spirometry and peak expiratory flow monitoring. In this context, various markers of airway inflammation (e.g. eosinophils in the induced sputum, nitric oxide in the exhaled air) have been proposed to assess the severity of asthma and to adjust the therapy accordingly. The evaluation of airway hyper-responsiveness with different stimuli has also been suggested as a new tool to monitor asthma. However, the lack of definite relationships between airway inflammation and asthmatic symptoms strongly limit the use of markers of asthma severity in the clinical setting. Therefore, the need of new tools to assess the severity of asthma is raised. The ideal measurement employed to establish the proper asthmatic therapy should be safe, non-invasive, easy to perform, reproducible and accurate, and have the capability to monitor the changes induced by the therapeutic interventions. A careful review of the available techniques, and the evaluation of their sensitivity and specificity in the clinical setting is warranted.Keywords
This publication has 114 references indexed in Scilit:
- Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary diseaseThorax, 2002
- Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthmaJournal of Allergy and Clinical Immunology, 2001
- Exhaled nitric oxide levels correlate with measures of disease control in asthmaJournal of Allergy and Clinical Immunology, 2000
- Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in childrenAnnals of Allergy, Asthma & Immunology, 1999
- Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patientsEuropean Respiratory Journal, 1997
- Nitric oxide and asthmatic inflammationImmunology Today, 1995
- Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group.Thorax, 1994
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Assessing cost‐effectiveness in asthma care: building an economic model to study the impact of alternative intervention strategiesAllergy, 1993
- Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humansBiochemical and Biophysical Research Communications, 1991